Cargando…
Generation of fourteen isogenic cell lines for Parkinson’s disease-associated leucine-rich repeat kinase (LRRK2)
Mutations in leucine-rich repeat kinase 2 (LRRK2) are associated with inherited forms of Parkinson’s disease (PD), causing disease by a gain of kinase function. Here, we describe a series of isogenic iPSC lines with any of five pathogenic mutations (N1437H, R1441C, Y1699C, G2019S and I2020T); two hy...
Autores principales: | Beylina, Aleksandra, Langston, Rebekah G., Rosen, Dorien, Reed, Xylena, Cookson, Mark R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8314873/ https://www.ncbi.nlm.nih.gov/pubmed/34087985 http://dx.doi.org/10.1016/j.scr.2021.102354 |
Ejemplares similares
-
Coding and Noncoding Variation in
LRRK2
and Parkinson's Disease Risk
por: Lake, Julie, et al.
Publicado: (2021) -
Inhibitors of Leucine Rich Repeat Kinase 2 (LRRK2) Protect Against LRRK2-Models of Parkinson’s Disease
por: Lee, Byoung Dae, et al.
Publicado: (2010) -
Function and dysfunction of leucine-rich repeat kinase 2 (LRRK2):
Parkinson’s disease and beyond
por: Bae, Jae Ryul, et al.
Publicado: (2015) -
Leucine-rich repeat kinase 2 mutations and Parkinson’s disease: three questions
por: Greggio, Elisa, et al.
Publicado: (2009) -
Evaluation of Current Methods to Detect Cellular Leucine-Rich Repeat Kinase 2 (LRRK2) Kinase Activity
por: Fernández, Belén, et al.
Publicado: (2022)